This post was originally published on this site
IDEXX Labs announced earnings per share of $2.24 on revenue of $836.55M. Analysts polled by Investing.com anticipated EPS of $2.26 on revenue of $839.47M.
IDEXX Labs shares are down 6% from the beginning of the year, still down 38.29% from its 52 week high of $706.51 set on August 4, 2021. They are outperforming the S&P 500 which is down 12.39% from the start of the year.
IDEXX Labs’s report follows an earnings beat by J&J on April 19, who reported EPS of $2.67 on revenue of $23.43B, compared to forecasts EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on April 14 with first quarter EPS of $5.49 on revenue of $80.15B, compared to forecast for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
